Strides Pharma Science Limited
The Abu Dhabi Investment Authority increased its stake in Strides Pharma Science Limited from 1.33% to 1.46%, purchasing 1,23,425 shares.
A pharmaceutical manufacturer engaged in developing and producing a diverse range of drug formulations for global distribution. The company operates across multiple therapy segments and maintains manufacturing facilities serving customers in over 100 countries. Strides Pharma has pursued strategic acquisitions and inorganic expansion to strengthen its market presence, diversify business segments, enhance therapy offerings, and build robust production infrastructure.
Sovereign wealth fund of the Emirate of Abu Dhabi, established in 1976 and one of the world's largest SWFs with around USD 1 trillion in assets. Long-term, multi-decade horizon. Indian equities sit inside its emerging markets allocation and ADIA is a consistent anchor in marquee Indian IPOs and large-block deals.